Acadia Healthcare (NASDAQ:ACHC) Hits New 1-Year Low – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $39.60 and last traded at $39.90, with a volume of 51596 shares traded. The stock had previously closed at $39.83.

Analyst Ratings Changes

A number of equities analysts have issued reports on ACHC shares. KeyCorp started coverage on Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Barclays cut their price objective on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. Deutsche Bank Aktiengesellschaft lifted their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, October 1st. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Friday, September 20th. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $86.67.

Acadia Healthcare Price Performance

The stock has a market cap of $3.68 billion, a price-to-earnings ratio of 13.06, a price-to-earnings-growth ratio of 1.78 and a beta of 1.33. The company has a 50-day simple moving average of $59.60 and a two-hundred day simple moving average of $66.10. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.91 EPS. As a group, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ACHC. Blue Trust Inc. increased its holdings in shares of Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the last quarter. GAMMA Investing LLC boosted its stake in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in Acadia Healthcare in the 2nd quarter valued at $59,000. Covestor Ltd boosted its stake in Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after purchasing an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale bought a new stake in Acadia Healthcare in the 3rd quarter valued at $86,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.